UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Anti-C1q antibodies as a follow-up marker in SLE patients

PloS one, 2015-04, Vol.10 (4), p.e0123572-e0123572

2015

Link zum Volltext

Verfügbarkeit prüfen

The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography

PloS one, 2018-10, Vol.13 (10), p.e0202105-e0202105

2018

Link zum Volltext

Verfügbarkeit prüfen

Worse cardiovascular and renal outcome in male SLE patients

Scientific reports, 2023-10, Vol.13 (1), p.18628-18628, Article 18628

2023

Link zum Volltext

Verfügbarkeit prüfen

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

PloS one, 2011-06, Vol.6 (6), p.e21338-e21338

2011

Link zum Volltext

Verfügbarkeit prüfen

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus

PloS one, 2018-01, Vol.13 (1), p.e0188695-e0188695

2018

Link zum Volltext

Verfügbarkeit prüfen

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

Frontiers in immunology, 2023, Vol.14, p.1255292-1255292

2023

Link zum Volltext

Verfügbarkeit prüfen

Association between low levels of Mannan-binding lectin and markers of autoimmune thyroid disease in pregnancy

PloS one, 2013-12, Vol.8 (12), p.e81755-e81755

2013

Link zum Volltext

Verfügbarkeit prüfen

Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients

PloS one, 2013-01, Vol.8 (1), p.e51983-e51983

2013

Link zum Volltext

Verfügbarkeit prüfen

Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus

Rheumatic & musculoskeletal diseases open, 2020-09, Vol.6 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

142 Autoantibodies against complement C1q induced by Epstein Barr Virus antigen exacerbate renal disease in lupus-prone mice

Immunobiology (1979), 2023-09, Vol.228 (5), p.152593, Article 152593

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q autoantibodies from systemic lupus erythematosus patients induce C1q production by macrophages

Immunobiology (1979), 2016-10, Vol.221 (10), p.1147-1147

2016

Link zum Volltext

Verfügbarkeit prüfen

136 Complement C1q and von Willebrand Factor interaction in atherosclerosis of human carotid artery

Immunobiology (1979), 2023-09, Vol.228 (5), p.152587, Article 152587

2023

Link zum Volltext

Verfügbarkeit prüfen

Critical incidents in a tertiary care clinic for internal medicine

BMC research notes, 2013-07, Vol.6 (1), p.276-276, Article 276

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery disease

Clinica chimica acta, 2024-05, Vol.558, p.119668-119668, Article 119668

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of lectin pathway protein levels and genetic variants early after injury with outcomes after severe traumatic brain injury. A prospective cohort study

Molecular immunology, 2017-09, Vol.89, p.212-213

2017

Link zum Volltext

Verfügbarkeit prüfen

Binding of von Willebrand factor to complement C1q on a cholesterol crystal surface

Molecular immunology, 2017-09, Vol.89, p.137-137

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of critical core amino acids of a major linear C1q epitope recognized by SLE auto-antibodies

Immunobiology (1979), 2012-11, Vol.217 (11), p.1176-1176

2012

Link zum Volltext

Verfügbarkeit prüfen

SaO039RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (CONESTAT ALFA) IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN HIGH-RISK PATIENTS (PROTECT): A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND SINGLE-CENTER TRIAL

Nephrology, dialysis, transplantation, 2019-06, Vol.34 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein-Barr virus-derived antigenic site

Molecular immunology, 2018-10, Vol.102, p.222-222

2018

Link zum Volltext

Verfügbarkeit prüfen

TO011BAFF AND IMMUNE COMPLEXES CONSISTING OF BAFF AND IMMUNOGLOBULIN G ARE ASSOCIATED WITH RENAL INVOLVEMENT AND DISEASE ACTIVITY IN SLE

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii82-iii82

2017

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human C1 esterase inhibitor

Trials, 2021-01, Vol.22 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Complement Activation Is Associated With Disease Severity in Multiple Sclerosis

Neurology : neuroimmunology & neuroinflammation, 2024-03, Vol.11 (2), p.e200212-e200212

2024

Link zum Volltext

Verfügbarkeit prüfen

Lectin pathway proteins and association with complement activation and disease activity in patients with Systemic Lupus Erythematosus

Molecular immunology, 2017-09, Vol.89, p.117-117

2017

Link zum Volltext

Verfügbarkeit prüfen

O38 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE

Lupus science & medicine, 2020, Vol.7 (Suppl 1), p.A29

2020

Link zum Volltext

Verfügbarkeit prüfen

P138 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE

Lupus science & medicine, 2020, Vol.7 (Suppl 1), p.A97

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Anti-C1q antibodies as a follow-up marker in SLE patients

The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography

Worse cardiovascular and renal outcome in male SLE patients

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

Association between low levels of Mannan-binding lectin and markers of autoimmune thyroid disease in pregnancy

Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients

Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus

142 Autoantibodies against complement C1q induced by Epstein Barr Virus antigen exacerbate renal disease in lupus-prone mice

Anti-C1q autoantibodies from systemic lupus erythematosus patients induce C1q production by macrophages

136 Complement C1q and von Willebrand Factor interaction in atherosclerosis of human carotid artery

Critical incidents in a tertiary care clinic for internal medicine

Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery disease

Association of lectin pathway protein levels and genetic variants early after injury with outcomes after severe traumatic brain injury. A prospective cohort study

Binding of von Willebrand factor to complement C1q on a cholesterol crystal surface

Identification of critical core amino acids of a major linear C1q epitope recognized by SLE auto-antibodies

SaO039RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (CONESTAT ALFA) IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN HIGH-RISK PATIENTS (PROTECT): A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND SINGLE-CENTER TRIAL

Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein-Barr virus-derived antigenic site

TO011BAFF AND IMMUNE COMPLEXES CONSISTING OF BAFF AND IMMUNOGLOBULIN G ARE ASSOCIATED WITH RENAL INVOLVEMENT AND DISEASE ACTIVITY IN SLE

Recombinant human C1 esterase inhibitor

Complement Activation Is Associated With Disease Severity in Multiple Sclerosis

Lectin pathway proteins and association with complement activation and disease activity in patients with Systemic Lupus Erythematosus

O38 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE

P138 Preclinical and clinical characterization of cenerimod, a potent, selective, and orally active sphingosine-1-phosphate receptor 1 modulator in SLE

Aktive Filter

Suchergebnisse filtern